Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gal Keren-Paz

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Urology|August 31, 2007
The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: a critical analysis of basic science and clinical dataJuza Chen, Gal Keren-Paz, Yuval Bar-Yosef, et al.
The Israel Medical Association Journal : IMAJ|August 6, 2010
Tubeless percutaneous nephrolithotomy: first 200 cases in IsraelMario Sofer, Ghalib Lidawi, Gal Keren-Paz, et al.
Harefuah|April 28, 2007
[Pediatric endourology]Mario Sofer, Gal Keren-Paz, Joseph Beniamyni, et al.
The Canadian Journal of Urology|February 24, 2024
A combined MRI-PSAD risk stratification system for prioritizing prostate biopsiesNoam Bar-Yaakov, Ziv Savin, Ibrahim Fahoum, et al.
Urologic Oncology|August 3, 2021
Anterior and apical samplings during transperineal image-guided prostate biopsyZiv Savin, Snir Dekalo, Ron Marom, et al.
Urologic Oncology|May 20, 2023
The role of tumor density in predicting significant cancer on targeted biopsy of the prostateGuy Erlich, Ziv Savin, Ibrahim Fahoum, et al.
Urologic Oncology|August 12, 2020
The effect of delaying transperineal fusion biopsy of the prostate for patients with suspicious MRI findings-Implications for the COVID-19 eraZiv Savin, Snir Dekalo, Ron Marom, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 17, 2025
MRI suspicious lesions in patients under active surveillance: Do systematic biopsies still add value?Ziv Savin, Reuben Ben-David, Avishay Shem-Tov Dlugy, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
Do 5-Alpha Reductase Inhibitors Influence the Features of Suspicious Lesions on Magnetic Resonance Imaging and Targeted Biopsy Results for Prostate Cancer Diagnosis?Ziv Savin, Avishay Shem-Tov Dlugy, Miri Grinbaum, et al.
The Canadian Journal of Urology|September 1, 2024
MRI-based PI-RADS score predicts ISUP upgrading and adverse pathology at radical prostatectomy in men with biopsy ISUP 1 prostate cancerSnir Dekalo, Ohad Mazliah, Eyal Barkai, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Urology|August 31, 2007
The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: a critical analysis of basic science and clinical dataJuza Chen, Gal Keren-Paz, Yuval Bar-Yosef, et al.
The Israel Medical Association Journal : IMAJ|August 6, 2010
Tubeless percutaneous nephrolithotomy: first 200 cases in IsraelMario Sofer, Ghalib Lidawi, Gal Keren-Paz, et al.
Harefuah|April 28, 2007
[Pediatric endourology]Mario Sofer, Gal Keren-Paz, Joseph Beniamyni, et al.
The Canadian Journal of Urology|February 24, 2024
A combined MRI-PSAD risk stratification system for prioritizing prostate biopsiesNoam Bar-Yaakov, Ziv Savin, Ibrahim Fahoum, et al.
Urologic Oncology|August 3, 2021
Anterior and apical samplings during transperineal image-guided prostate biopsyZiv Savin, Snir Dekalo, Ron Marom, et al.
Urologic Oncology|May 20, 2023
The role of tumor density in predicting significant cancer on targeted biopsy of the prostateGuy Erlich, Ziv Savin, Ibrahim Fahoum, et al.
Urologic Oncology|August 12, 2020
The effect of delaying transperineal fusion biopsy of the prostate for patients with suspicious MRI findings-Implications for the COVID-19 eraZiv Savin, Snir Dekalo, Ron Marom, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 17, 2025
MRI suspicious lesions in patients under active surveillance: Do systematic biopsies still add value?Ziv Savin, Reuben Ben-David, Avishay Shem-Tov Dlugy, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
Do 5-Alpha Reductase Inhibitors Influence the Features of Suspicious Lesions on Magnetic Resonance Imaging and Targeted Biopsy Results for Prostate Cancer Diagnosis?Ziv Savin, Avishay Shem-Tov Dlugy, Miri Grinbaum, et al.
The Canadian Journal of Urology|September 1, 2024
MRI-based PI-RADS score predicts ISUP upgrading and adverse pathology at radical prostatectomy in men with biopsy ISUP 1 prostate cancerSnir Dekalo, Ohad Mazliah, Eyal Barkai, et al.
Pageof 2